News
-
-
-
-
-
-
REGULATED PRESS RELEASE
Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares
InVivo Group completes public buy-out offer of TERACT shares acquiring majority control, initiates squeeze-out. AMF to oversee procedure. TERACT, a key player in responsible distribution markets, now part of InVivo's network of brands -
-
PRESS RELEASE
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
ElevAATe phase 2 study shows efdoralprin alfa surpassing traditional therapy in achieving and maintaining fAAT levels in AATD patients with emphysema. Results presented at 2026 ATS International Conference -
-
